Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises IRLAB Therapeutics in connection with share issues
Mandate

Vinge advises IRLAB Therapeutics in connection with share issues

December 13, 2019 Capital Markets and Public M&A

Vinge advises IRLAB Therapeutics in connection with a directed share issue of SEK 70 million and a rights issue of approximately SEK 145 million.

The directed share issue was subscribed for by a number of institutional and qualified investors on the basis of an accelerated book building process. The rights issue is expected to be completed during the first quarter of 2020.

IRLAB Therapeutics is a research and development company, listed on Nasdaq First North Premier Growth Market, focused on development of novel therapies for the treatment of neurodegenerative diseases, in particular Parkinson’s disease and dementia.

Vinge’s team has consisted of Dain Hård Nevonen, Nils Fredrik Dehlin, Stephanie Stiernstedt, Stojan Arnerstål, Anna Thoms and Maria Schultzberg.

Related

Vinge has advised Ingrid Capacity in new co-operation with Locus Energy, one of SEB Nordic Energy's portfolio companies

 Vinge has advised Ingrid Capacity in connection with a new project together with Locus Energy, a leading Nordic energy infrastructure company owned by SEB Asset Management's SEB Nordic Energy fund, to develop Finland's largest and one of the Nordic region's largest battery storage systems.
March 07, 2025

Vinge has advised Great Security and Garda Group in connection with the acquisition of Comdate Norrlarm

 Vinge has advised Great Security, one of Sweden’s largest security companies, in connection with the acquisition of Comdate Norrlarm, the largest independent alarm and security company in northern Sweden. The acquisition strengthens Great Security’s presence in the region and provides direct access to this geographical market.
March 06, 2025

Vinge advises SpareBank 1 Markets in connection with its partnership with Swedbank

 The partnership between SpareBank 1 Markets and Swedbank aims to create a leading Nordic investment bank. As part of the transaction, SpareBank 1 Markets will receive Swedbank’s Corporate Finance and DCM High-Yield business in Sweden and establish a branch in Stockholm through which the business operations will be conducted.
March 04, 2025